Angene Chemical
Draw
|
Currency :
Home Products

AG000IYR

1195765-45-7 | Benzenesulfonamide, N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-

Chemical structure of Benzenesulfonamide, N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-, CAS 1195765-45-7
AG000IYR
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 1195765-45-7
Catalog Number AG000IYR
Chemical Name Benzenesulfonamide, N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-
EC Number 689-166-9
IUPAC Name N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide
InChI InChI=1S/C23H20F3N5O2S2/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25/h4-11,31H,1-3H3,(H2,27,28,29)
InChI Key BFSMGDJOXZAERB-UHFFFAOYSA-N
MDL Number MFCD17215684
Molecular Formula C23H20F3N5O2S2
Molecular Weight 519.5624
SMILES O=S(C1=C(F)C=CC=C1F)(NC2=CC=CC(C3=C(C4=NC(N)=NC=C4)SC(C(C)(C)C)=N3)=C2F)=O
UNII QGP4HA4G1B
Synonyms
dabrafenib, GSK 2118436, GSK-2118436, GSK2118436, Dabrafenib, 1195765-45-7, Dabrafenib (GSK2118436), Tafinlar, GSK2118436A, UNII-QGP4HA4G1B, GSK 2118436, Dabrafenib (Free Base), QGP4HA4G1B, N-(3-(5-(2-aminopyrimidin-4-yl)-2-tert-butylthiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide, CHEBI:75045, N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(tert-butyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide, N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide, N-{3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide, GSK-2118436A, Dabrafenib Mesylate (GSK-2118436), Dabrafenib [USAN:INN], N-{3-[5-(2-aminopyrimidin-4-yl)-2-tert-butylthiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide, P06, Dabrafenib (USAN), Tube719, dabrafenib-gsk2118436, MLS006011052, SCHEMBL806377, GTPL6494, CHEMBL2028663, C23H20F3N5O2S2, DABRAFENIB, KB-57246, DTXSID20152499, QCR-129, BFSMGDJOXZAERB-UHFFFAOYSA-N, HMS3656D12, AOB87722, API01001, BCP09341, EX-A1320, KS-000005OR, ABP001006, BDBM50428286, FD5028, GSK 2118436A, MFCD17215684, ZINC68153186, (GSK2118436) pound notDabrafenib, AKOS024463285, AKOS032950004, CS-0692, DB08912, SB13355, NCGC00346716-01, NCGC00346716-14, 4CA-0431, AC-25889, AS-19634, BC297817, HY-14660, SMR004702844, AB0087834, AX8262770, S2807, SW219503-1, Y1871, A11381, D10064, W-5688, AB01565833_02, J-004153, BRD-K09951645-066-01-2, Benzenesulfonamide, N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-, N-(3-(5-(2-aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide, N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(tert-butyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluorobenzenesulfo, N-{3-(5-(2-aminopyrimidin-4-yl)-2-(1,1-dimethylethyl)thiazol-4-yl)-2-fluorophenyl}-2,6- difluorobenzenesulfonamide, N-{3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide, Dabrafenib mesylate, dabrafenib mesilate, GSK2118436, D05ROI, D0BO9V, Dabrafenib (BRAF inhibitor), GSK2118436B, GSK 2118436B, 1195765-45-7 (free base), ACN-041315, GSK-2118436, A3347, B1407, C561627, 1195768-06-9, Dabrafenib, 98%, a mutant BRAFV600 specific inhibitor - 100MG 100mg,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited